Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme

Insulin degrading enzyme (IDE) plays key roles in degrading peptides vital in type two diabetes, Alzheimer's, inflammation, and other human diseases. However, the process through which IDE recognizes peptides that tend to form amyloid fibrils remained unsolved. We used cryoEM to understand both...

Full description

Bibliographic Details
Main Authors: Zhening Zhang, Wenguang G Liang, Lucas J Bailey, Yong Zi Tan, Hui Wei, Andrew Wang, Mara Farcasanu, Virgil A Woods, Lauren A McCord, David Lee, Weifeng Shang, Rebecca Deprez-Poulain, Benoit Deprez, David R Liu, Akiko Koide, Shohei Koide, Anthony A Kossiakoff, Sheng Li, Bridget Carragher, Clinton S Potter, Wei-Jen Tang
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2018-03-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/33572
_version_ 1811252957701734400
author Zhening Zhang
Wenguang G Liang
Lucas J Bailey
Yong Zi Tan
Hui Wei
Andrew Wang
Mara Farcasanu
Virgil A Woods
Lauren A McCord
David Lee
Weifeng Shang
Rebecca Deprez-Poulain
Benoit Deprez
David R Liu
Akiko Koide
Shohei Koide
Anthony A Kossiakoff
Sheng Li
Bridget Carragher
Clinton S Potter
Wei-Jen Tang
author_facet Zhening Zhang
Wenguang G Liang
Lucas J Bailey
Yong Zi Tan
Hui Wei
Andrew Wang
Mara Farcasanu
Virgil A Woods
Lauren A McCord
David Lee
Weifeng Shang
Rebecca Deprez-Poulain
Benoit Deprez
David R Liu
Akiko Koide
Shohei Koide
Anthony A Kossiakoff
Sheng Li
Bridget Carragher
Clinton S Potter
Wei-Jen Tang
author_sort Zhening Zhang
collection DOAJ
description Insulin degrading enzyme (IDE) plays key roles in degrading peptides vital in type two diabetes, Alzheimer's, inflammation, and other human diseases. However, the process through which IDE recognizes peptides that tend to form amyloid fibrils remained unsolved. We used cryoEM to understand both the apo- and insulin-bound dimeric IDE states, revealing that IDE displays a large opening between the homologous ~55 kDa N- and C-terminal halves to allow selective substrate capture based on size and charge complementarity. We also used cryoEM, X-ray crystallography, SAXS, and HDX-MS to elucidate the molecular basis of how amyloidogenic peptides stabilize the disordered IDE catalytic cleft, thereby inducing selective degradation by substrate-assisted catalysis. Furthermore, our insulin-bound IDE structures explain how IDE processively degrades insulin by stochastically cutting either chain without breaking disulfide bonds. Together, our studies provide a mechanism for how IDE selectively degrades amyloidogenic peptides and offers structural insights for developing IDE-based therapies.
first_indexed 2024-04-12T16:43:36Z
format Article
id doaj.art-bdf640b40b944a06bfcc72ce62dd4071
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T16:43:36Z
publishDate 2018-03-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-bdf640b40b944a06bfcc72ce62dd40712022-12-22T03:24:41ZengeLife Sciences Publications LtdeLife2050-084X2018-03-01710.7554/eLife.33572Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzymeZhening Zhang0Wenguang G Liang1Lucas J Bailey2Yong Zi Tan3https://orcid.org/0000-0001-6656-6320Hui Wei4Andrew Wang5Mara Farcasanu6Virgil A Woods7Lauren A McCord8David Lee9Weifeng Shang10Rebecca Deprez-Poulain11Benoit Deprez12David R Liu13Akiko Koide14Shohei Koide15Anthony A Kossiakoff16Sheng Li17Bridget Carragher18https://orcid.org/0000-0002-0624-5020Clinton S Potter19https://orcid.org/0000-0003-2394-0831Wei-Jen Tang20https://orcid.org/0000-0002-8267-8995National Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United StatesBen-May Institute for Cancer Research, The University of Chicago, Chicago, United StatesDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, United StatesNational Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, United StatesNational Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United StatesBen-May Institute for Cancer Research, The University of Chicago, Chicago, United StatesBen-May Institute for Cancer Research, The University of Chicago, Chicago, United StatesDepartment of Medicine, University of California, San Diego, La Jolla, United StatesBen-May Institute for Cancer Research, The University of Chicago, Chicago, United StatesDepartment of Medicine, University of California, San Diego, La Jolla, United StatesBioCAT, Argonne National Laboratory, Illinois, United StatesUniv. Lille, INSERM, Institut Pasteur de Lille, Lille, FranceUniv. Lille, INSERM, Institut Pasteur de Lille, Lille, FranceDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, United StatesPerlmutter Cancer Center, New York University School of Medicine, New York, United States; New York University Langone Medical Center, New York University School of Medicine, New York, United States; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United StatesPerlmutter Cancer Center, New York University School of Medicine, New York, United States; New York University Langone Medical Center, New York University School of Medicine, New York, United States; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United StatesDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, United StatesDepartment of Medicine, University of California, San Diego, La Jolla, United StatesNational Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, United StatesNational Resource for Automated Molecular Microscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, United States; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, United StatesBen-May Institute for Cancer Research, The University of Chicago, Chicago, United StatesInsulin degrading enzyme (IDE) plays key roles in degrading peptides vital in type two diabetes, Alzheimer's, inflammation, and other human diseases. However, the process through which IDE recognizes peptides that tend to form amyloid fibrils remained unsolved. We used cryoEM to understand both the apo- and insulin-bound dimeric IDE states, revealing that IDE displays a large opening between the homologous ~55 kDa N- and C-terminal halves to allow selective substrate capture based on size and charge complementarity. We also used cryoEM, X-ray crystallography, SAXS, and HDX-MS to elucidate the molecular basis of how amyloidogenic peptides stabilize the disordered IDE catalytic cleft, thereby inducing selective degradation by substrate-assisted catalysis. Furthermore, our insulin-bound IDE structures explain how IDE processively degrades insulin by stochastically cutting either chain without breaking disulfide bonds. Together, our studies provide a mechanism for how IDE selectively degrades amyloidogenic peptides and offers structural insights for developing IDE-based therapies.https://elifesciences.org/articles/33572insulinamyloid peptideinsulin degrading enzymeproteostasiscryoEMintegrative structural biology
spellingShingle Zhening Zhang
Wenguang G Liang
Lucas J Bailey
Yong Zi Tan
Hui Wei
Andrew Wang
Mara Farcasanu
Virgil A Woods
Lauren A McCord
David Lee
Weifeng Shang
Rebecca Deprez-Poulain
Benoit Deprez
David R Liu
Akiko Koide
Shohei Koide
Anthony A Kossiakoff
Sheng Li
Bridget Carragher
Clinton S Potter
Wei-Jen Tang
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
eLife
insulin
amyloid peptide
insulin degrading enzyme
proteostasis
cryoEM
integrative structural biology
title Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
title_full Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
title_fullStr Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
title_full_unstemmed Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
title_short Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
title_sort ensemble cryoem elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
topic insulin
amyloid peptide
insulin degrading enzyme
proteostasis
cryoEM
integrative structural biology
url https://elifesciences.org/articles/33572
work_keys_str_mv AT zheningzhang ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT wenguanggliang ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT lucasjbailey ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT yongzitan ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT huiwei ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT andrewwang ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT marafarcasanu ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT virgilawoods ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT laurenamccord ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT davidlee ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT weifengshang ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT rebeccadeprezpoulain ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT benoitdeprez ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT davidrliu ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT akikokoide ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT shoheikoide ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT anthonyakossiakoff ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT shengli ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT bridgetcarragher ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT clintonspotter ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme
AT weijentang ensemblecryoemelucidatesthemechanismofinsulincaptureanddegradationbyhumaninsulindegradingenzyme